Evoke Pharma Inc. (EVOK)
NASDAQ: EVOK
· Real-Time Price · USD
5.69
-0.65 (-10.25%)
At close: Aug 22, 2025, 12:28 PM
Evoke Pharma Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -5.38M | -5.08M | -5.35M | -6.15M | -6.53M | -7.13M | -7.79M | -7.61M | -7.93M | -8.29M | -8.22M | -8.09M | -8.05M | -8.11M | -8.54M | -9.13M | -9.29M | -13.97M |
Depreciation & Amortization | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Stock-Based Compensation | 581.15K | 603.48K | 773.12K | 793.83K | 944K | 1.1M | 1.13M | 1.2M | 1.28M | 1.36M | 1.46M | 1.56M | 1.67M | 1.7M | 1.88M | 1.9M | 1.92M | 1.88M |
Other Working Capital | -238.74K | 221.09K | -435.01K | 41.99K | -133.59K | -380.75K | 556.12K | -412.39K | -440.8K | -94K | 48.49K | 276.91K | 277.9K | -97.94K | -797.02K | 4.37M | 3.99M | 4.03M |
Other Non-Cash Items | 1.31M | 926.87K | 1.71M | 1.58M | 1.49M | 1.01M | 129.07K | 140.3K | 321.89K | 716.99K | 1.13M | 1.13M | 1.43M | 993.86K | 442.93K | -4.64M | -5.11M | -104.17K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -132.98K | 62.38K | -1.4M | -360.52K | -265.53K | -118.05K | 1.55M | -118.83K | 94.86K | 244.76K | 132.41K | 406.05K | -4.53M | -4.64M | -5.62M | 323.15K | 4.5M | 4.16M |
Operating Cash Flow | -3.62M | -3.88M | -5.46M | -5.32M | -5.55M | -5.93M | -4.98M | -6.39M | -6.44M | -6.61M | -6.6M | -6.09M | -10.88M | -11.01M | -12.35M | -12.07M | -7.99M | -8.03M |
Capital Expenditures | 5.00 | n/a | n/a | n/a | -5 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | 5.00 | 5.00 | 5.00 | 5.00 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 3M | 3M | 3M |
Common Stock Repurchased | -191 | -191 | -191 | -191 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2.71M | 2.71M |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 13.2M | 13.49M | 14.32M | 3.98M | 1M | 705.21K | -119.3K | -148.99K | n/a | -148.99K | -148.99K | 313.11K | 164.11K | -946.28K | -946.28K | -1.05M | -945.41K | 5.73M |
Financial Cash Flow | 6.5M | 6.8M | 14.32M | 10.7M | 7.72M | 7.42M | -119.3K | 7.29K | 7.29K | 7.13M | 7.3M | 7.29M | 7.61M | 530.08K | 13.43M | 16.93M | 16.72M | 22.08M |
Net Cash Flow | 2.88M | 2.92M | 8.86M | 5.37M | 2.17M | 1.49M | -5.1M | -6.39M | -6.44M | 511.6K | 698.99K | 1.21M | -3.27M | -10.48M | 1.08M | 4.86M | 8.73M | 14.05M |
Free Cash Flow | -3.62M | -3.88M | -5.46M | -5.32M | -5.55M | -5.93M | -4.98M | -6.39M | -6.44M | -6.61M | -6.6M | -6.09M | -10.88M | -11.01M | -12.35M | -12.07M | -7.99M | -8.03M |